Linked e-resources
Details
Table of Contents
Intro; Preface; Contents; Acronyms; 1 Introduction to Contrast-Enhanced Imaging; 1.1 Imaging Technology; 1.1.1 Magnetic Resonance Imaging; 1.1.2 Ultrasound Imaging; 1.1.3 X-ray Imaging and Computed Tomography; 1.1.4 Nuclear Scintigraphy; 1.2 Contrast Agents and Image Enhancement; References; 2 Introduction to Pharmacokinetic Modeling; 2.1 Indicator Dilution Theory; 2.2 Modeling of Contrast Kinetics; 2.3 Model Fitting and Regression Techniques; References; 3 Intravascular Contrast Agents; 3.1 Imaging and Calibration; 3.1.1 Ultrasound Contrast Agents; 3.1.2 Blood Pool MR Contrast Agents
3.2 Pharmacokinetic Modeling3.3 Clinical Applications; 3.3.1 Cardiology; 3.3.2 Oncology; References; 4 Extravascular Contrast Agents; 4.1 Imaging and Calibration; 4.1.1 Dynamic Contrast-Enhanced CT (DCE-CT); 4.1.2 Dynamic Contrast-Enhanced MRI (DCE-MRI); 4.2 Pharmacokinetic Modeling; 4.2.1 Compartmental (Lumped) Models; 4.2.2 Distributed Models; 4.2.3 Modeling of Vascular Transport; 4.3 Clinical Applications; 4.3.1 Cardiology; 4.3.2 Oncology; References; 5 Molecular Contrast Agents; 5.1 Imaging and Calibration; 5.1.1 PET and SPECT Radioactive Tracers; 5.1.2 US Molecular Contrast Agents
5.1.3 MR Molecular Contrast Agents5.1.4 CT Molecular Contrast Agents; 5.2 Pharmacokinetic Modeling; 5.2.1 PET and SPECT Radioactive Tracers; 5.2.2 US Molecular Contrast Agents; 5.2.3 MR Molecular Contrast Agents; 5.3 Clinical Applications; 5.3.1 Cardiology; 5.3.2 Oncology; References
3.2 Pharmacokinetic Modeling3.3 Clinical Applications; 3.3.1 Cardiology; 3.3.2 Oncology; References; 4 Extravascular Contrast Agents; 4.1 Imaging and Calibration; 4.1.1 Dynamic Contrast-Enhanced CT (DCE-CT); 4.1.2 Dynamic Contrast-Enhanced MRI (DCE-MRI); 4.2 Pharmacokinetic Modeling; 4.2.1 Compartmental (Lumped) Models; 4.2.2 Distributed Models; 4.2.3 Modeling of Vascular Transport; 4.3 Clinical Applications; 4.3.1 Cardiology; 4.3.2 Oncology; References; 5 Molecular Contrast Agents; 5.1 Imaging and Calibration; 5.1.1 PET and SPECT Radioactive Tracers; 5.1.2 US Molecular Contrast Agents
5.1.3 MR Molecular Contrast Agents5.1.4 CT Molecular Contrast Agents; 5.2 Pharmacokinetic Modeling; 5.2.1 PET and SPECT Radioactive Tracers; 5.2.2 US Molecular Contrast Agents; 5.2.3 MR Molecular Contrast Agents; 5.3 Clinical Applications; 5.3.1 Cardiology; 5.3.2 Oncology; References